Hearing Status in Patients with Type 2 Diabetes Mellitus According to Blood-Sugar Control: A Comparative Study

Document Type: Original

Authors

1 Rhino-sinus, Ear and Skull base Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran .

2 Department of Endocrinology, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.

3 Department of Otolaryngology, Head and Neck Surgery and Research Center, Amiralmomenin Hospital, Guilan University of Medical Sciences, Rasht, Iran.

Abstract

Introduction:
It seems that diabetes mellitus (DM) can affect the auditory system due to neuropathy, micro-vascular complications, and hearing cell damage during hyperglycemic states. In the current study, we aimed to compare hearing status in patients with type 2 DM (T2DM) according to their blood-sugar control status.
 
Materials and Methods:
This cross-sectional study was carried out in 104 patients with T2DM attending the diabetic clinics of Guilan University of Medical Sciences within a period of 1 year (2014–2015). One group consisted of 52 patients with poor control and the other consisted of patients with moderate-to-good control (according to glycated hemoglobin [HbA1c] level). All subjects underwent pure tone audiometry (PTA) and distortion product otoacoustic emission (DPOAEs) assessments. A hearing threshold higher than 20 dB and a signal-to-noise ratio ≤3 in each frequency were considered abnormal.
 
Results:
In PTA, poorly controlled patients showed more frequent hearing loss compared with the well-controlled group, especially at higher frequencies (8 kHz: 67.3% vs 46.2% [P=0.029]; 10 kHz: 46.2% vs 21.2% [P=0.025]). Also, patients in the poorly controlled group had worse cochlear function according to the DPOAE test (4 kHz: 32.7% vs 17.3% [P= 0.002] and 8 kHz: 70.6% vs 40.4% [P=0.006]).
 
Conclusion:
DM and poor control status of diabetes can affect hearing sensation and cause hearing loss, especially at high frequencies. According to our findings, it seems that diabetic patients with a duration of diabetes >10 years, diabetic complications, poor control status or comorbidities should undergo both endocrine and audiologic follow-up to prevent greater sensory neural hearing loss.

Keywords

Main Subjects


1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care. 2004;27:1047–53.

2. Mozaffari M, Tajik A, Ariaei N, Ali-Ehyaii F, Behnam H. Diabetes mellitus and sensorineural hearing loss among non-elderly people. Eastern Mediterr Health J 2010; 16:947–52.

3. World Health Organization – Diabetes country profiles, 2016. Available from: http://www. who.int/diabetes/country-profiles/irn_en.pdf?ua=1.

4. Ferreira JC, Guimarães R, Becker H, Silva C, Gonçalves T, Crosara P. Avaliação metabólica do paciente com labirintopatia. Arq Otorrinolaringol. 2000;4:28–32.

5. Marchiori LLdM, Gibrin PCD. Diabetes mellitus: prevalência de alterações auditivas. Arquivos Brasileiros de Endocrinologia & Metabologia. 2003; 47:82–6.

6. Malucelli DA, Malucelli FJ, Fonseca VR, Zeigeboim B, Ribas A, Trotta F, et al. Hearing loss prevalence in patients with diabetes mellitus type 1. Braz J Otorhinolaryngol. 2012; 78:105–15.

7.  Frisina ST, Mapes F, Kim S, Frisina DR, Frisina RD. Characterization of hearing loss in aged type II diabetics. Hearing Res. 2006;211:103–13.

8. Parving A, Elberling C, Balle V, Parbo J, Dejgaard A, Parving HH. Hearing disorders in patients with insulin-dependent diabetes mellitus. Audiology. 1990;29:113–21.

9. Virtaniemi J, Laakso M, Nuutinen J, Karjalainen S, Vartiainen E. Hearing thresholds in insulin-dependent diabetic patients. J Laryngol Otol. 1994; 108:837–41.

10. Gibbin KP, Davis CG. A hearing survey in diabetes mellitus. Clinical Otolaryngol Allied Sci. 1981; 6:345–50.

11. Harner SG. Hearing in adult-onset diabetes mellitus. Otolaryngol Head Neck Surg 1981; 89: 322–7.

12. Miller JJ, Beck L, Davis A, Jones DE, Thomas AB. Hearing loss in patients with diabetic retinopathy. Am J Otolaryngol 1983;4:342–6.

13. Virtaniemi J, Laakso M, Nuutinen J, Karjalainen S, Vartiainen E. Hearing thresholds in insulin-dependent diabetic patients. J Laryngol Otol 1994;108:837–41.

14. Axelsson A, Fagerberg SE. Auditory Function in Diabetics. Acta Otolaryngol 1968; 66:49–64.

15. Salvinelli F, Miele A, Casale M, Greco F, D'Ascanio L, Firrisi L. Hearing Thresholds in Patients With Diabetes. Int J Otorhinolaryngol. 2004;3(1).

16. Çayönü M, Çapraz M, Acar A, Altundağ A, Murat S. Hearing Loss Related with Type 2 Diabetes in an Elderly Population. J Int Adv Otolo. 2014;10:72–5.

17. Axelsson A, Sigroth K, Vertes D. Hearing in diabetics. Acta Otolaryngol Supplement. 1978; 356: 1–23.

18. Cullen JR, Cinnamond MJ. Hearing loss in diabetics. J Laryngol Otol. 1993;107:179–82.

19. Rajendran S, Anandhalakshmi, Mythili B, Viswanatha R. Evaluation of the incidence of sensorineural hearing loss in patients with type 2 diabetes mellitus. Int J Biol Med Res.2011;2:982-7.

20. Lisowska G, Namyslowski G, Morawski K, Strojek K. Cochlear dysfunction and diabetic microangiopathy. Scand Audiol Suppl. 2001; 52: 199–203.

21. Park MS, Park SW, Choi JH. Distortion product otoacoustic emissions in diabetics with normal hearing. Scand Audiol Suppl. 2001;52: 148–51.

22. Bayýndýr T, Erdem T, Uzer E, Toplu k, Sarý R, zturan O. Evaluation of the Auditory Effects in Controlled and Uncontrolled Type 2 Diabetes Mellitus Using Otoacoustic Emissions. J Turgut Ozal Med Cent. 2010;17:337–41.

23. Ferreira JM, Câmara MFeS, Almeida PCd, Brandão Neto J, Silva CABd. Características audiológicas de pacientes com diabetes mellitus Tipo 2. Revista CEFAC. 2016;18:1050–9.

24. Joshi KD, Galagali JR, Kanzhuly MK, Singh ID. A comparative study on effects of diabetes on auditory functions as measured by BERA and DPOAE. Int J Otorhinolaryngol Head Neck Surg. 2017;3:347–53.

25. Panchu P. Auditory acuity in type 2 diabetes mellitus. Int J Diabetes Develop Countr. 2008; 28:114–20.

26. Gibrin PC, Melo JJ, Marchiori LL. Prevalence of tinnitus complaints and probable association with hearing loss, diabetes mellitus and hypertension in elderly. CoDAS. 2013;25:176–80.

27. Doroszewska G, Kazmierczak H. Hyperinsulinemia in vertigo, tinnitus and hearing loss]. Otolaryngologia Polska. 2002;56:57–62.

28. Orts Alborch M, Morant Ventura A, Garcia Callejo J, Perez del Valle B, Lorente R, Marco Algarra J. The study of otoacoustic emissions in diabetes mellitus. Acta Otorrinolaringologica Espanola. 1998;49:25–8.

29. Angeli RD, Lavinsky L, Dolganov A. Alterations in cochlear function during induced acute hyperinsulinemia in an animal model. Braz J Otorhinolaryngol. 2009;75:760–4.

30. Maia FC, Lavinsky L, Mollerke RO, Duarte ME, Pereira DP, Maia JE. Distortion product otoacoustic emissions in sheep before and after hyperinsulinemia induction. Braz J Otorhinolaryngol. 2008;74:181–7.

31. Safavi Naini A, Fathololoomi MR, Safavi Naini A. Effect of Diabetes Mellitus on the Hearing Ability of Diabetic Patients. Tanaffos. 2003;2:   51–8.

32. Swaminathan A, Sambandam R, Bhaskaran M. Evaluation of the auditory effects of hyperlipidaemia and diabetes mellitus by using audiometry. J Clin Diagnost Res. 2011;5:1528–32.

33. Fukushima H, Cureoglu S, Schachern PA, Kusunoki T, Oktay MF, Fukushima N, et al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg 2005; 133: 100–6.